Market revenue in 2023 | USD 1,813.6 million |
Market revenue in 2030 | USD 4,567.7 million |
Growth rate | 14.1% (CAGR from 2023 to 2030) |
Largest segment | Cell-based research |
Fastest growing segment | In-vitro fertilization |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Drug Discovery, In-vitro fertilization, Vaccine production, Cell-based research, Diagnostics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to fetal bovine serum market will help companies and investors design strategic landscapes.
Cell-based research was the largest segment with a revenue share of 28.35% in 2023. Horizon Databook has segmented the Global fetal bovine serum market based on drug discovery, in-vitro fertilization, vaccine production, cell-based research, diagnostics covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of global-level data and insights on the Global fetal bovine serum market , including forecasts for subscribers. This global databook contains high-level insights into Global fetal bovine serum market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account